INSIGHTS ON DRUG DEVELOPMENT
-
![getty-1484506435-data-center]( "FAIR Data—What Does It Mean For The Lab Scientist?")
FAIR Data—What Does It Mean For The Lab Scientist?Over 70% of scientists don't know FAIR data, but it is key to AI and reproducibility. Learn how structured data transforms research efficiency and unlocks long-term value across R&D.
-
![GettyImages-1441343945-virus-viral-infection]( "A Simple Method For Cell Growth Media Preparation")
A Simple Method For Cell Growth Media PreparationExplore how powder media and sterile fluid handling can reduce contamination risk and improve efficiency in viral vector production, especially for HEK293-based AAV workflows.
-
![peptides-preclinical-develop-GettyImages-2264393871]( "How Peptides Became Cornerstones Of Modern Medicine")
How Peptides Became Cornerstones Of Modern MedicinePeptides evolved from early chemical discoveries to transformative therapies, culminating in GLP‑1 drugs that highlight their versatility, precision, and expanding role across modern medicine.
-
![GettyImages-1088537588 disease]( "EMA Support For Rare Disease Therapies")
EMA Support For Rare Disease TherapiesReview how the EMA supports rare disease drug development through regulatory and financial incentives for therapies that meet strict eligibility and ongoing compliance criteria.
-
Unified Lab Software For Modern QC Workflows8/17/2026
Manage increasingly complex chromatography workflows with a scalable data system that supports secure data management, instrument control, analysis, reporting, and high-resolution characterization.
-
An Alternative Method Of Drug-Excipient Characterization12/30/2024
Isothermal microcalorimetry (IMC) rapidly screens API-excipient compatibility, detecting physical and chemical interactions faster than conventional methods, saving time and effort in pharmaceutical formulation development.
-
Drug Development Plan Explained: DPP Templates And Examples7/27/2026
Only 6.7% of Phase 1 drugs reach approval. A well-structured Drug Development Plan (DDP) can meaningfully improve your odds — learn exactly how to build one.
-
Rethinking Design, Cost, And Scalability In Biomanufacturing3/24/2026
Life science teams increasingly need tools that scale, simplify workflows, and reduce operational costs. Examine how emerging instrumentation focuses on usability, performance, and manufacturability.
-
Integrated Stability Workflows That Reduce Manual Data Handling5/28/2026
Integrated accelerated stability workflows reduce manual data handling while improving confidence in shelf‑life predictions. Help your teams move faster with fewer experimental demands.
DRUG DEVELOPMENT SOLUTIONS
-
![Affinity-ITC]( "Microcalorimeters For In-Depth Characterization")
Powerful tools for characterizing protein-protein interactions, structural stability, and formulation compatibility.
-
![GettyImages-1441662840-lab-team-communication-collaboration]( "Integrated Programs To Bridge Molecules From Discovery Into Clinical Development")
A new collaboration helps to remove obstacles from the critical path, reduce development risks, eliminate the white space in pre-clinical drug development, and shorten the pathway to clinical development.
-
![Asahi Kasei - THESYS ACS_60 GA_003]( "Dynamic And Ergonomic Oligosynthesis Column")
These patented synthesis columns offer oligonucleotide manufacturers a system designed for efficiency and safety.
-
![iStock-1210343139-journey-computer-data-development]( "Where Expertise Meets Simplicity: BD PartnerPath™ Program")
The commercialization of a combination product can be a complex process that involves obtaining the proper data, choosing a drug delivery system, developing a regulatory strategy and conducting clinical trials—all of which can increase development risks and affect your molecule’s time to market.
-
![Scientist standing with SpectraMax iD5e mutlt-mode microplate reader gas mixer included]( "SpectraMax iD3s And iD5e Multi-Mode Microplate Readers")
Designed for today’s assays and tomorrow’s breakthroughs—flexible detection that evolves with your science.
The SpectraMax® iD3s and iD5e Multi-Mode Microplate Readers deliver flexible, scalable solutions for absorbance, fluorescence, and luminescence assays—with advanced capabilities for evolving research needs. The iD3s reader offers a streamlined, affordable platform with a tunable monochromator and temperature control, while the iD5e reader adds enhanced detection modes including time-resolved fluorescence (TRF) and tunable fluorescence polarization (FP) and can be expanded to include TR-FRET, HTRF, BRET and western blot. Both readers support on board fluidics with optional dual injectors.
